- For Quality Assurance: the discussion raises questions about whether existing workflows should be simplified before automation.
- For Validation and CSV: system changes after GMP validation can trigger additional revalidation and testing. Meanwhile,
- Manufacturing and Digital Quality: teams need standardized data and workflows that support operators rather than adding digital complexity.
Gilead Warns Pharma: Fix GMP Workflows Before Scaling AI
Gilead Sciences’ Anthony Mire-Sluis warned that pharma companies should simplify workflows and standardize data before scaling AI in GMP operations. He cited a 55-step approval process that gained little from simple digitization and a mock recall where one bottle had three different names across three sites.
At the same time, Gilead showed AI’s practical value: one internal tool can scan about 30,000 historical deviations in seconds and rank the most relevant cases, replacing lengthy manual searches.
Pfizer and GSK Show What Goes Wrong When Weak Processes Go Digital
Pfizer and GSK highlighted how weak processes can undermine digital transformation in GMP environments. Pfizer said an early deviation-management rollout across 37 sites struggled because local teams were not sufficiently involved, prompting a restart under its “Revolution” model. GSK, meanwhile, shifted toward simplification and removed 58 non-GMP-critical documentation steps. The message was clear: digital systems work best when companies simplify workflows and standardize processes before implementation.
The experiences shared by Gilead, Pfizer, and GSK show how different digital-quality problems can emerge before or during transformation. The table below compares the issue each company highlighted and the practical lesson for GMP teams.
| Company | Digital Quality Issue | What Happened | Practical Lesson for GMP Teams |
|---|---|---|---|
|
Gilead Sciences |
Process complexity and inconsistent data |
A mock recall found the same bottle described differently across three sites |
Simplify workflows and standardize data before scaling AI |
|
Pfizer |
Weak workflow transferred into a digital system |
An early deviation-management rollout across 37 sites struggled after insufficient site involvement |
Involve users and redesign workflows before implementation |
|
GSK |
Excessive documentation complexity |
A team removed 58 non-GMP-critical documentation steps |
Separate GMP-critical requirements from unnecessary process burden |
Before Scaling AI in GMP, Quality Teams Should Check These Controls
Quality teams can start by mapping the existing process with the employees who perform it, identifying unnecessary steps before digitalization, standardizing critical data across sites, and defining clear ownership. They should also plan how users will participate in system design and understand why the change is being introduced. These priorities reflect the approaches described by the speakers rather than new regulatory requirements.
Specialist question: If your current deviation workflow contains unnecessary approvals, would you validate the digital version first or simplify the process before beginning validation?
What Comes Next as Pharma Pushes AI Deeper Into Quality Operations
The report did not announce a new FDA or EMA regulatory decision. Instead, the next developments to watch are how Gilead, Pfizer and GSK continue deploying their quality-transformation programs and whether their approaches produce further measurable changes in deviation management, documentation simplification, data governance and workforce adoption.
From AI Ambition to GMP Control: Digital Solutions for Regulated Operations
For teams reviewing how to simplify and control digital GMP workflows, Zamann Pharma’s Digital Solutions for GMP-Regulated Operations is the most natural service match. The service covers areas including computerized system implementation, CSV, master data management and ongoing digital-system support; teams planning similar transformations can explore whether this support fits their current digital-quality priorities.
Source: Bio-Itworld.Com